Kornitzer Capital Management Inc. KS Acquires New Position in Guardian Pharmacy Services, Inc. $GRDN

Kornitzer Capital Management Inc. KS bought a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 50,000 shares of the company’s stock, valued at approximately $1,066,000.

A number of other large investors have also recently modified their holdings of GRDN. New York State Common Retirement Fund raised its holdings in shares of Guardian Pharmacy Services by 16.1% during the 1st quarter. New York State Common Retirement Fund now owns 323,257 shares of the company’s stock worth $6,872,000 after buying an additional 44,709 shares in the last quarter. Woodline Partners LP grew its position in Guardian Pharmacy Services by 1.5% in the first quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock valued at $8,955,000 after acquiring an additional 6,083 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in Guardian Pharmacy Services during the second quarter worth about $75,000. Peregrine Capital Management LLC raised its stake in Guardian Pharmacy Services by 56.1% during the first quarter. Peregrine Capital Management LLC now owns 176,539 shares of the company’s stock worth $3,753,000 after acquiring an additional 63,464 shares in the last quarter. Finally, Calamos Advisors LLC lifted its holdings in shares of Guardian Pharmacy Services by 61.5% in the first quarter. Calamos Advisors LLC now owns 39,919 shares of the company’s stock worth $849,000 after acquiring an additional 15,194 shares during the last quarter.

Guardian Pharmacy Services Price Performance

GRDN opened at $28.47 on Monday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $16.91 and a fifty-two week high of $30.39. The firm has a market capitalization of $1.80 billion and a price-to-earnings ratio of -18.73. The company’s 50 day moving average price is $26.20 and its two-hundred day moving average price is $23.49.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on GRDN shares. Truist Financial lifted their price target on shares of Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a report on Friday, September 26th. Wall Street Zen lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 3rd. Oppenheimer initiated coverage on shares of Guardian Pharmacy Services in a report on Friday, October 10th. They set an “outperform” rating and a $30.00 price target for the company. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Guardian Pharmacy Services in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $29.33.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.